Press Releases
-
Aug 13, 2018ZolpiMist Launches into the $1.8 billion U.S. Non-Benzodiazepine Prescription Sleep Aid Market...Aug 10, 2018ENGLEWOOD, CO / ACCESSWIRE / August 10, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significant medical needs, today announced that the company will effect a 1-for-20 reverse split of its issued and outstanding shares of common stock. The reverse stock split will become effective August 10, 2018 at...Jul 17, 2018University of Miami Study is First to Assess Natesto's Impact on Sperm Production and Gonadotropin Levels...Jul 10, 2018- Multi-Center, Global Study Demonstrates that MiOXSYS Provides an Accurate Measure of Seminal Oxidative Stress that can be Standardized Globally Within Clinical Andrology and IVF Laboratories - Presentations Made by Leading Andrologists and Infertility Experts, on a Growing Body of Clinical and Scientific Evidence, Support the Expanding use of the MiOXSYS Platform in Clinical Practice Around the ...Jun 13, 2018Company Acquires FDA-Approved, Commercial-Stage Product to Complement Natesto® Sales Efforts Among Primary Care Physicians...May 23, 2018ENGLEWOOD, CO / ACCESSWIRE / May 23, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, announced today that it will be presenting at the 8th Annual LD Micro Invitational investor conference on Tuesday, June 5th, at 9:00 AM PST / 11:00 AM EST at the Luxe Sunset Boulevard Hotel in Los Angeles,...May 14, 2018ENGLEWOOD, CO / ACCESSWIRE / May 14, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today provided an overview of its business, including the company's operational and financial results for its fiscal third quarter ended March 31, 2018. The company will host a live conference call and web...May 8, 2018ENGLEWOOD, CO / ACCESSWIRE / May 8, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, has highlighted its progress of the company's commercial strategy in the below letter to shareholders....May 7, 2018ENGLEWOOD, CO / ACCESSWIRE / May 7, 2018 / Aytu BioScience, Inc. (AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced that the company will present its operational results for the fiscal third quarter 2018 on Monday, May 14, 2018, at 4:30 p.m. ET. The company will review recent accomplishments and provide an overvi...May 3, 2018ENGLEWOOD, CO / ACCESSWIRE / May 3, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU) (the "Company"), a specialty life sciences company focused on global commercialization of novel products in the field of urology, has been featured in a local ABC News segment presented by medical specialist anchor Kristi Krueger: "UM doctors test new medication for treating men with low testosterone. Nasal testosteron...